Skip to main content

RED S

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Linnaeus Therapeutics
Linnaeus TherapeuticsNJ - Haddonfield
1 program
Relative Energy Deficiency in Sports (REDs) in Swedish AthletesN/A1 trial
Active Trials
NCT06371963Completed44Est. May 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Linnaeus TherapeuticsRelative Energy Deficiency in Sports (REDs) in Swedish Athletes

Clinical Trials (1)

Total enrollment: 44 patients across 1 trials

NCT06371963Linnaeus TherapeuticsRelative Energy Deficiency in Sports (REDs) in Swedish Athletes

Relative Energy Deficiency in Sports (REDs) in Swedish Athletes

Start: May 2022Est. completion: May 202444 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.